Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 683

Results For "ED"

8078 News Found

Universal vaccination for Covid-19 irrational: AIIMS Professor
News | February 03, 2022

Universal vaccination for Covid-19 irrational: AIIMS Professor

The need is to vaccinate people who have not contracted Covid-19


Caplin Point Q3FY22 PAT at Rs 74.95 cr.
News | February 03, 2022

Caplin Point Q3FY22 PAT at Rs 74.95 cr.

Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.


USFDA approves first generic of Restasis
Drug Approval | February 03, 2022

USFDA approves first generic of Restasis

Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug


Mylab launches CoviSwift for Covid-19 Point of Care testing
Medical Device | February 03, 2022

Mylab launches CoviSwift for Covid-19 Point of Care testing

Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals


More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun
interviews | February 02, 2022

More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun

Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health


Zydus supplies first consignment of its Covid-19 vaccine ZyCoV-D
News | February 02, 2022

Zydus supplies first consignment of its Covid-19 vaccine ZyCoV-D

The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST


Alembic receives USFDA tentative approval for fesoterodine fumarate
Drug Approval | February 02, 2022

Alembic receives USFDA tentative approval for fesoterodine fumarate

The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency


Panacea Biotec sells its domestic formulations business to Mankind Pharma
News | February 02, 2022

Panacea Biotec sells its domestic formulations business to Mankind Pharma

The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year


Windlas Biotech concludes SAHPRA audit with an all-clear sign
News | February 02, 2022

Windlas Biotech concludes SAHPRA audit with an all-clear sign

It will enable the company to branch out to new geographies and strengthen its presence in South Africa


Lupin signs deal with Axantia to market pegfilgrastim in Middle East and Africa
News | February 01, 2022

Lupin signs deal with Axantia to market pegfilgrastim in Middle East and Africa

Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy